Anemia can shift your A1c result in either direction, sometimes enough to change a diagnosis or alter how your diabetes is managed. The direction of the shift depends on the type of anemia: iron deficiency tends to push A1c readings falsely high, while conditions that shorten red blood cell lifespan, like hemolytic anemia or certain inherited blood disorders, tend to pull A1c falsely low. The size of the error varies from person to person and can be large enough to cross the thresholds used for diagnosing prediabetes and diabetes, which means getting the anemia sorted out is not just a side issue but a prerequisite for trusting the number.
Why A1c Depends on Red Blood Cell Survival
A1c measures the percentage of hemoglobin in your red blood cells that has glucose stuck to it. That attachment happens gradually over a red blood cell’s lifetime, which is normally around 120 days. The longer a red blood cell circulates, the more glucose it accumulates on its hemoglobin. A1c essentially averages your blood sugar exposure over roughly two to three months because that is how long most red blood cells last before the body recycles them.
Anything that changes how long your red blood cells survive changes how much glycation they accumulate, regardless of what your actual blood sugar is doing. If red blood cells are destroyed early, hemoglobin has less time to collect glucose, and A1c reads artificially low. If red blood cells hang around longer than normal, hemoglobin keeps accumulating glucose, and A1c reads artificially high. Research using biotin-labeled red blood cells in people with and without diabetes has confirmed that the natural variation in red blood cell lifespan among otherwise healthy people is large enough to produce clinically meaningful differences in A1c for any given average blood sugar level.1PubMed Central. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c Anemia amplifies this problem because many types of anemia directly interfere with red blood cell production, destruction, or both.
Iron Deficiency Anemia Pushes A1c Up
Iron deficiency anemia is by far the most common form of anemia worldwide, and it nudges A1c readings in a direction that surprises most people: upward. You might expect any anemia to lower A1c, but iron deficiency does the opposite. One study of people with controlled blood sugar found that those with iron deficiency anemia had elevated A1c compared to controls, with even higher readings in women.2PubMed Central. Influence of Iron Deficiency Anemia on Hemoglobin A1C Levels in Diabetic Individuals with Controlled Plasma Glucose Levels The exact mechanism is still debated, but the leading explanation centers on red blood cell turnover. When your body is starved of iron, it produces fewer new red blood cells, so the ones already circulating tend to be older on average. Older cells have had more time to accumulate glycated hemoglobin, which inflates the A1c reading.3PubMed Central. Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review
The practical risk here is a false diagnosis. If you have unrecognized iron deficiency anemia and your doctor orders an A1c to screen for diabetes, the result could land in the prediabetic or diabetic range even though your blood sugar is actually normal. A large U.S. population study cautioned that clinicians should be careful when interpreting A1c values near the diagnostic cutoffs of 5.7% (prediabetes) and 6.5% (diabetes) in people with abnormal hemoglobin levels, since changes in red blood cell turnover can shift the result.4PubMed. Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US
Laboratory methodology also plays a role. Different assay techniques can magnify or mask the effect of iron deficiency on A1c readings. One Japanese study found that when red blood cells from iron-deficient patients were isolated and measured with an enzymatic assay, the A1c values came out significantly higher than when whole blood from the same patients was measured using standard chromatography methods.5PubMed Central. Blood cell HbA1c measured by enzymatic assay show higher than whole blood HbA1c in patients with iron deficiency anemia This means the size of the false elevation can depend partly on which lab technique your hospital uses.
When Anemia Pulls A1c Down
Conditions that destroy red blood cells prematurely, collectively called hemolytic anemias, push A1c in the opposite direction. Because the red blood cells are being broken down faster than normal, hemoglobin does not get enough time exposed to glucose, and the A1c result comes in lower than the person’s actual blood sugar would warrant. Modeling research has found that A1c underestimation becomes more pronounced as red blood cell lifespan drops, with a steep inflection point around 66 days. When red blood cell survival falls below roughly 90 days, A1c consistently underestimates blood sugar; below 66 days the underestimation becomes particularly dramatic.6Frontiers in Endocrinology. Rectify the impact of shorter red blood cell lifespan upon HbA1c detection values in T2DM patients: modeling and internal-external verification
This is the more dangerous direction of error for someone with diabetes. A falsely low A1c can create the illusion that blood sugar is well controlled when it is not, leading to under-treatment. One case report described a patient with paroxysmal nocturnal hemoglobinuria, a rare condition that destroys red blood cells, whose A1c kept coming back reassuringly low even though other markers showed ongoing high blood sugar.7PubMed. Misleading hemoglobin A1c levels in a patient with paroxysmal nocturnal hemoglobinuria Only when the clinical team checked fructosamine and glycated albumin did the true extent of the hyperglycemia become apparent.
Blood loss has a similar effect. Donating blood or losing blood during surgery triggers your bone marrow to ramp up production of new, young red blood cells. These fresh cells have had almost no time to accumulate glycated hemoglobin, so they dilute the A1c measurement downward. A study of patients with diabetes who donated their own blood before elective surgery found that both hemoglobin and A1c dropped after donation.8PubMed Central. Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus The takeaway: if you have donated blood recently or had significant bleeding, your next A1c test may read lower than your actual glucose control warrants.
Thalassemia and Inherited Hemoglobin Variants
Thalassemia, a group of inherited conditions that affect hemoglobin production, interacts with A1c in a way that depends heavily on which type you carry and how severe it is. Mild forms are common in many populations and may not cause obvious symptoms, but they can still interfere with A1c measurement.
For alpha-thalassemia, the picture is relatively clear-cut. People who carry one or two deleted alpha genes, the milder forms, show A1c values that are not significantly different from people without thalassemia. However, individuals with the more severe form known as HbH disease, where only one functional alpha gene remains, have A1c levels that are significantly lower than their actual blood sugar would predict.9PubMed Central. Effects of α-Thalassemia on HbA1c Measurement Their red blood cells are fragile and turn over faster, shortening hemoglobin’s exposure to glucose.
Beta-thalassemia trait, the heterozygous carrier state, is far more prevalent. A cross-sectional study found that carriers had slightly lower A1c values than non-carriers, but the difference was small, roughly 0.23%, and clinically this was judged to be of limited impact. The authors concluded that A1c remains a reasonable diagnostic tool even in people with beta-thalassemia trait.10Clinica Chimica Acta. Effect of heterozygous beta thalassemia on HbA1c levels in individuals without diabetes mellitus: A cross sectional study That said, rarer and more severe beta-thalassemia mutations can produce a larger effect. A case report documented an abnormally low A1c in a patient with a clinically silent but rare beta-thalassemia variant, identified only through gene sequencing.11Frontiers in Endocrinology. Case Report: Abnormally Low Glycosylated Hemoglobin A1c Caused by Clinically Silent Rare β-Thalassemia in a Tujia Chinese Woman So even when the thalassemia itself does not cause noticeable symptoms, it can still distort A1c.
Other hemoglobin variants beyond thalassemia can also interfere. Hemoglobin C trait, for instance, was identified in one patient only after continuous glucose monitoring revealed that her self-monitored blood glucose readings did not match her persistently elevated A1c values. The CGM data confirmed that her blood sugar was better controlled than her A1c suggested, prompting the eventual genetic diagnosis.12PubMed Central. Use of Continuous Glucose Monitoring Leads to Diagnosis of Hemoglobin C Trait in a Patient With Discrepant Hemoglobin A1c and Self-Monitored Blood Glucose
Vitamin B12 and Folate Deficiency
Deficiencies in vitamin B12 or folate cause megaloblastic anemia, where the body produces abnormally large, dysfunctional red blood cells. Like iron deficiency, B12 deficiency has been linked to falsely elevated A1c readings. In one study, correcting the B12 deficiency with supplementation led to a measurable drop in A1c: on average, a 0.94 g/dL rise in hemoglobin after treatment was associated with a 0.24 percentage-point decrease in A1c.13PubMed Central. Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia
The misclassification potential is striking. In a study of patients with B12 deficiency who had been classified as prediabetic based on A1c values, the average A1c dropped from about 6.0% at baseline to 5.4% after six months of treatment. Among those initially labeled prediabetic, about nine out of ten were reclassified as non-diabetic once their B12 deficiency was corrected.14Global Journal of Health Science and Research. Vitamin B12 deficiency masks true glycemic status: HbA1c misclassification in pre-diabetic patients In other words, a large majority of those “prediabetes” diagnoses were driven by the vitamin deficiency, not by actual blood sugar problems. The authors recommended ruling out B12 deficiency before making a diagnosis or changing treatment based on A1c.
Interestingly, one study comparing different anemia types in people without diabetes found that the average A1c in megaloblastic anemia was not significantly different from controls. The authors observed a mean A1c of about 5.38% in the megaloblastic anemia group versus the control group.15PubMed Central. The effect of different types of anemia on HbA1c levels in non-diabetics This seemingly contradictory result likely reflects differences in severity of the deficiency across study populations, and it is a reminder that the magnitude of the A1c distortion depends on how severe the anemia actually is.
What Happens When Iron Deficiency Gets Treated
One of the clearest demonstrations that iron deficiency distorts A1c comes from watching what happens when the deficiency is corrected. A systematic review and meta-analysis found that across most included studies, iron replacement therapy led to a decrease in A1c levels in patients with iron deficiency anemia.16PubMed Central. The Effect of Iron Replacement Therapy on HbA1c Levels in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis The drop occurs because replenishing iron stores allows the bone marrow to resume making red blood cells at a normal rate, replacing the older, heavily glycated cells with younger ones and bringing the A1c back to a level that more accurately reflects blood sugar.
A study from India tracked non-diabetic individuals with iron deficiency anemia before and after iron supplementation and observed a significant decline in A1c, from about 5.5% to 5.0% after treatment. Among those whose pre-treatment A1c fell in the prediabetic range, the vast majority dropped back into the normal range once their iron stores were replenished.17Clinica Chimica Acta. Effect of iron deficiency anemia and iron supplementation on HbA1c levels – Implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians If you are told you have prediabetes and also happen to be iron deficient, it is worth revisiting the A1c after the deficiency has been treated.
Pregnancy Adds Another Layer
Iron deficiency anemia is extremely common during pregnancy, affecting over half of pregnant women in some countries. This creates a particularly tricky diagnostic situation because gestational diabetes also needs to be screened for. A systematic review found that A1c levels were slightly elevated in pregnant women with iron deficiency anemia compared to non-pregnant women, driven by a combination of hormonal changes, increased insulin resistance, and the iron deficiency itself disrupting glucose metabolism.18PubMed Central. Exploring the Impact of Iron Deficiency Anaemia on Glycated Haemoglobin A1c Levels in Pregnant and Non-Pregnant Women: A Systematic Review
This creates a real risk of overdiagnosis. A study examining pregnant women’s A1c values noted that iron deficiency anemia, rather than actual hyperglycemia, is often the reason for an elevated A1c during pregnancy.19Journal of Obstetrics, Gynecology and Cancer Research. Evaluation of the Combination of HbA1C with Hematocrit for Early Screening of Gestational Diabetes Mellitus Because of these confounders, most clinical guidelines already recommend the oral glucose tolerance test rather than A1c as the primary screening tool for gestational diabetes. But A1c is still sometimes used in prenatal care for monitoring known diabetes, and in that context, the iron deficiency artifact matters.
EPO Therapy and Chronic Kidney Disease
People with chronic kidney disease often develop anemia because their kidneys produce less erythropoietin, the hormone that stimulates red blood cell production. Treatment with synthetic erythropoietin (EPO drugs like epoetin alfa and darbepoetin alfa) can powerfully suppress A1c, independent of any change in blood sugar. One case report described a patient with diabetes and kidney disease whose A1c dropped to 4.4% while on EPO therapy. Five months after the EPO was stopped, his A1c bounced back up to 8.8%.20PubMed. Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis The authors concluded that the artificially low A1c had likely led to undertreatment of his diabetes during the months he was on EPO. This effect makes sense mechanistically: EPO floods the bloodstream with young red blood cells that have barely had time to accumulate glycated hemoglobin, dragging down the A1c average.
Alternatives When A1c Cannot Be Trusted
When anemia or a hemoglobin variant makes A1c unreliable, doctors have other options. The two most established alternatives are fructosamine and glycated albumin. Both measure glucose attached to serum proteins rather than to hemoglobin, so they are not affected by red blood cell lifespan at all. They reflect a shorter window of blood sugar control, roughly two to three weeks instead of two to three months, which makes them useful both as A1c substitutes and as complements when short-term control matters.21PubMed Central. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol Glycated albumin in particular has been validated as a useful indicator of glycemic control in patients with hemolytic anemia.22Clinica Chimica Acta. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia
Continuous glucose monitoring offers yet another route. CGM devices measure interstitial glucose directly and produce a metric called time in range, which shows how many hours per day your blood sugar stays within target. Because CGM does not depend on hemoglobin at all, it sidesteps every anemia-related artifact. CGM data can also be used to calculate a glucose management indicator (GMI), which estimates what A1c “should” be based on the sensor glucose average. Comparing your actual lab A1c with the GMI can reveal discordance that points to an unrecognized hemoglobin issue, as happened in the case where CGM use led to the unexpected discovery of hemoglobin C trait.12PubMed Central. Use of Continuous Glucose Monitoring Leads to Diagnosis of Hemoglobin C Trait in a Patient With Discrepant Hemoglobin A1c and Self-Monitored Blood Glucose
Personalized A1c and the Future of Glucose Monitoring
The fundamental problem with A1c is that it treats everyone’s red blood cells as if they behave identically, and they do not. Researchers have built mathematical models that combine glucose monitoring data with estimates of patient-specific red blood cell kinetics to calculate a personalized A1c. One such model, published in a major translational medicine journal, found that between-patient variation in mean red blood cell age accounted for all of the glucose-independent variation in A1c. When this personalized approach was applied prospectively, errors in estimating average glucose dropped by more than half across groups of over 200 patients.23PubMed Central. Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring
These personalized models are not yet standard clinical practice, but the concept is making its way into real-world care through the growing use of CGM. As sensor-derived metrics like GMI become more widely available, clinicians can compare the lab A1c against the CGM-derived estimate and flag patients whose values diverge. A mismatch does not always mean anemia, but it does mean something is altering the relationship between glucose and hemoglobin glycation, and anemia is one of the first things worth investigating.24PubMed. Personalized Glycated Hemoglobin in Diabetes Management: Closing the Gap with Glucose Management Indicator
How to Know If Your A1c Might Be Off
There is no single test that tells you “your A1c is wrong by X percent.” But there are red flags worth paying attention to. If your A1c does not match your home glucose readings or CGM data, if it shifts abruptly without a change in diet or medication, or if you have a known or suspected blood disorder, it is reasonable to ask your doctor whether the number is trustworthy. Specific situations that warrant suspicion include:
- Recent blood loss or donation: your A1c may read lower than your actual control for several weeks afterward.
- Iron or B12 deficiency: your A1c may read higher than your actual control, and the effect resolves with supplementation.
- EPO or similar medications: the surge of young red blood cells can drive A1c down significantly.
- Thalassemia or sickle cell trait: depending on severity and variant, A1c can be shifted in either direction, and the standard assay may not flag the interference.
- Pregnancy with anemia: the combination of iron deficiency and physiological changes can inflate A1c and mimic gestational diabetes.
If any of these apply to you, a fructosamine or glycated albumin test can serve as a cross-check. For people with diabetes who have CGM access, the GMI comparison described above is increasingly the easiest way to spot a problem. The goal is not to abandon A1c, which remains a useful and well-validated tool for most people, but to recognize the circumstances where it needs a second opinion.